NCT03109470撤回不适用
The Durability of Early RA Disease Control After Tocilizumab Withdrawal: A Canadian Experience
Pope Research Corporation0 个研究点开始时间: 2012年11月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 发起方
- 主要终点
- Rate of Biologic Treatment
研究概览
简要总结
Patients who participated in the FUNCTION Study (Protocol WA19926) will be enrolled in this study. The investigators want to learn how long it takes Early Rheumatoid Arthritis patients who were treated with Tocilizumab to require treatment with another biologic medication.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Completed 2 years in the FUNCTION (WA19926) trial
- •Patient has provided written informed consent and is willing to comply with the requirements of this study protocol
排除标准
- •Requirement for immediate treatment with a biologic therapy following completion of the FUNCTION (WA19926) trial as per treating physician judgement.
- •Presence of any condition that, in the opinion of the treating physician, prohibits the patient from participating in the study or obscures the assessment of the treatment of RA
结局指标
主要结局
Rate of Biologic Treatment
时间窗: 2 years
To describe the rate of requiring biologic treatment over 2 years following completion of the FUNCTION study
次要结局
- Treatment after completion of FUNCTION study(Baseline)
- Change in functional status(2 years)
- Healthcare Utilization(2 years)
- Work productivity(2 years)
- Rate of requiring treatment intensification(2 years)
研究者
相似试验
已完成
不适用
A Study of Duration of Maintained Efficacy in Rheumatoid Arthritis (RA) Patients Off Treatment With MRA(a Development Code of Tocilizumab, an Anti IL-6 Receptor Monoclonal Antibody.)Rheumatoid ArthritisNCT00661284Chugai Pharmaceutical189
已完成
不适用
Long-term Observation of Patients With Early Rheumatoid ArthritisRheumatoid ArthritisNCT00240136University of California, Los Angeles372
Unknown
2 期
Early Response-adapted Intensification of Induction Chemotherapy in Patients With Newly Diagnosed Multiple Myeloma (MM)Multiple MyelomaNCT01114048Chonnam National University Hospital78
已完成
2 期
An Efficacy and Safety Study of Simeprevir and Sofosbuvir With and Without Ribavirin in Participants With Recurrent Genotype 1 Hepatitis C Post-Orthotopic Liver TransplantHepatitits CNCT02165189Janssen Scientific Affairs, LLC46
Enrolling By Invitation
不适用
RACE 2: a Long Term Follow-up of Patients Participating in the RACE TrialSevere Aplastic AnemiaNCT05049668European Society for Blood and Marrow Transplantation197